Purchase Order 75N91019P00610
Award Date
8/1/19
Potential Completion Date
1/31/24
Potential Value
$15K
Federal Agency
National Cancer Institute
Awardee
Akoya Biosciences, Inc.
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Francisco, CA 94108, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the procurement of one (1) CODEX instrument from Akoya Biosciences, Inc. (doing business as Phenoptics) by the National Cancer Institute (NCI), Center for Cancer Research (CCR), Experimental Transplantation and Immunology Branch (ETIB). The award, valued at $84,000.00, is a firm fixed-price purchase order placed under simplified acquisition procedures for commercial items. The CODEX instrument supports the Transplantation Therapy Section's ongoing research into...
This federal contract award was made by the National Institute of Dental and Craniofacial Research (NIDCR), a civilian agency under the National Institutes of Health (NIH), to Akoya Biosciences, Inc., doing business as Phenoptics. The $98,600 firm-fixed-price purchase order is for the delivery of Codex fluidics instrumentation, which are specialized laboratory equipment for medical research applications. The contract has no set-aside designation and was awarded on a competitive, non-set-aside...
Akoya Biosciences, Inc., doing business as Phenoptics, has been awarded a firm fixed price purchase order by the Department of Health and Human Services' National Institutes of Health National Cancer Institute. The contract has a potential value of $11,417 and calls for Akoya to provide services in support of the agency's medical imaging, diagnostic testing, and pathology operations located in Bethesda, Maryland. No set-aside designation was applied to this award. Akoya specializes in spatial...
This federal contract award is for the procurement of PHENOCYCLER REAGENTS by the National Cancer Institute (NCI), a civilian agency under the U.S. Department of Health and Human Services. The $12,737.00 firm fixed price purchase order was awarded to Akoya Biosciences, Inc., doing business as Phenoptics, a for-profit biotechnology company and manufacturer of goods. This contract is not designated as a small business set-aside. Akoya Biosciences has been awarded numerous federal contracts and...
This is a firm fixed-price purchase order awarded by the National Cancer Institute to Akoya Biosciences, Inc. (doing business as Phenoptics), a self-certified small disadvantaged business manufacturer of goods, for a service contract to provide a PhenoCycler instrument. The total ceiling value of the contract is $10,020.00, and the ultimate completion date is July 30, 2025. The award is not associated with a set-aside program. Akoya Biosciences is a biotechnology company that specializes in...
This is a firm fixed price purchase order awarded by the National Institutes of Health (NIH) National Cancer Institute to Akoya Biosciences, Inc., a self-certified small disadvantaged business. The contract has a potential value of $16,560.00 and a period of performance through April 30, 2025. Akoya, operating under the trade name Phenoptics, will provide goods and services to support medical imaging, diagnostic testing, and pathology operations. This includes the delivery of OPAL reagent packs,...
This is a $12,000 firm fixed price purchase order awarded by the National Cancer Institute to Akoya Biosciences, Inc. (doing business as Phenoptics), a self-certified small disadvantaged business. The contract is for software upgrades, with a period of performance through July 17, 2024. Akoya Biosciences specializes in spatial phenotyping and provides medical imaging, diagnostic testing, and pathology products and services to support healthcare operations, including for the Department of...
The National Institutes of Health National Cancer Institute awarded Akoya Biosciences, Inc., doing business as Phenoptics, a $470,560 firm fixed price purchase order to provide their Spatial Tissue Exploration Program (STEP) of Human Central Nervous System (CNS) Tumors. As the prime contractor, Phenoptics will utilize their multiplexed immunofluorescence and quantitative pathology capabilities to analyze human CNS tumor samples as part of the Health and Human Services agency's efforts to advance...
This firm fixed price BPA Call order from the National Cancer Institute, part of the National Institutes of Health within the Department of Health and Human Services, is valued at twenty-four thousand eight hundred fifty-seven dollars and eighty-four cents ($24,857.84). Prime contractor 10X Genomics, Inc. will provide single cell kits to the Chen Lab members at its Pleasanton, California location for use in single-cell analysis and research from November 16, 2022 through December 15, 2022. ...
The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $10,482.50 firm fixed price purchase order to Cytek Biosciences, Inc. Cytek Biosciences Division for SERVICE AGREEMENT. The place of performance will be in Bethesda, Maryland. The period of performance is from November 1, 2023 through January 31, 2024. As the National Cancer Institute conducts research into cancer causes, prevention, diagnosis, and treatment, this purchase order is...